CHESS Health company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Unattributed | Alive

Total Raised


Last Raised

$1.9M | 4 yrs ago

Mosaic Score

+50 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About CHESS Health

CHESS Health creates solutions designed at the intersection of science, technology, and recovery. CHESS developed A-CHESS, an evidence-based relapse prevention technology. By integrating A-CHESS into treatment plans, clinicians, case managers and coaches can best support those in recovery with access to predictive relapse analytics, condition-specific content and access to live support, reducing relapse by 50 percent while decreasing costs and saving lives.

CHESS Health Headquarter Location

333 West Commercial Street Suite 2500

East Rochester, New York, 14445,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CHESS Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CHESS Health is included in 1 Expert Collection, including Digital Health.


Digital Health

13,495 items

Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)

Latest CHESS Health News

NIH starts trial of Pear, Chess apps for opioid use disorder

Jun 29, 2021

June 29, 2021 Patient recruitment has begun in a National Institutes of Health (NIH) trial of two digital therapeutics (DTx) for people with opioid use disorder (OUD), developed by Pear Therapeutics and Chess Health. The CTN-0100 study is test strategies to help keep people with OUD on drug treatment, improve the chances that those stabilised with drug treatments for OUD can come off medication without relapsing, as well as to find ways to predict the risk of relapse based on patient characteristics. The study is testing various drug regimens along with Pear’s prescription app reSET-O and Chess Health’s free Connections app, given on top of standard medical management for OUD. The digital apps are based on cognitive behavioural therapy (CBT) and are intended to be used alongside standard treatment for OUD – including pharmacological therapy with drugs like buprenorphine – to reduce opioid use and boost retention with treatment. In CTN-0100, reSET-O and Connections will be given alongside either Indivior’s Suboxone (transmucosal buprenorphine), Braeburn/Camurus’ Brixadi (injectable buprenorphine), or Alkermes’ Vivitrol (injectable naltrexone), according to the study protocol. Final results are not due until 2026, according to the entry for the trial on the database, although interim results may be available sooner. The trial is part of the NIH Heal initiative, which was launched in 2018 to fund scientific approaches to solving the US opioid overdose crisis, including improved treatment strategies for pain as well as OUD. In 2019, the NIH allocated $945 million in funding for the scheme. Both reSET-O and Connections were included in an assessment by the influential Institute for Clinical and Economic Review (ICER), which concluded that neither of the apps – or another DTx from DynamiCare Health – have data from a randomised clinical trial showing they can enhance long-term abstinence or retention rates. Of the three, ICER was able to develop a cost-effectiveness model only for reSET-O, which was approved by the FDA in 2018, as there wasn’t enough clinical data on the other two to make an assessment. From 1999–2019, nearly 500,000 people died from an overdose involving any opioid, including prescription and illicit opioids, according to the latest figures from the US Centre for Disease Control and Prevention (CDC). In 2019, more than 70% of the 70,630 deaths recorded in that year involved an opioid. Don't miss your daily pharmaphorum news.

May 6, 2020
CHESS Health

CHESS Health Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

CHESS Health Rank

  • When was CHESS Health founded?

    CHESS Health was founded in 2014.

  • Where is CHESS Health's headquarters?

    CHESS Health's headquarters is located at 333 West Commercial Street, East Rochester.

  • What is CHESS Health's latest funding round?

    CHESS Health's latest funding round is Unattributed.

  • How much did CHESS Health raise?

    CHESS Health raised a total of $1.9M.

  • Who are the investors of CHESS Health?

    Investors of CHESS Health include Wisconsin Alumni Research Foundation.

  • Who are CHESS Health's competitors?

    Competitors of CHESS Health include Pear Therapeutics and 5 more.

You May Also Like

Pear Therapeutics Logo
Pear Therapeutics

Pear Therapeutics discovers, develops, and delivers clinically-validated Prescription Digital Therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effection solutions for payers.

DynamiCare Health Logo
DynamiCare Health

DynamiCare Health is a digital platform that helps people monitor and reduce the use of drugs, opioids, alcohol, and tobacco. DynamiCare Health allows people to perform substance tests through our app anytime, anywhere, through connected breath and saliva tests verified by selfie video.

Quit Genius Logo
Quit Genius

Quit Genius has created a gamified behavioral therapy app to help smokers quit smoking.

Hello Sunday Morning Logo
Hello Sunday Morning

Hello Sunday Morning is an Australian not-for-profit organization dedicated to helping people who want to change their relationship with alcohol.

Workit Health Logo
Workit Health

Workit provides a 90-day digital program that pairs one-on-one support from professionally-certified counselors with interactive, customized digital content. The core of the program is based on evidence-based therapies for addiction, including Motivational Interviewing (MI), Relapse Prevention Therapy, (RPT), Cognitive Behavioral Therapy (CBT), and Brief Interventions (BI).

Lionrock Logo

Lionrock provides treatment online for alcohol abuse, drug addiction, and other substance use disorders by secure video conference.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.